Eastern Allergy Conference Product Theaters
Product Theaters are an option only available to full conference registrants
and is not for CME credit
_____________________________________________________________________________
KalVista
Thursday, May 29, 2025
2:30 – 3:15 PM ~ Ponce 1&2
Closing Gaps in HAE Management: Understanding What Control Means for Your HAE Patients
Raffi Tachdjian, MD and Shahnaz Fatteh, MD
AstraZeneca
Thursday, May 29, 2025
6:35 – 7:20 PM ~ Ponce 1&2
Shifting the Paradigm: Clinical Evidence for Anti-Inflammatory Rescue
Miguel Lanz, MD and Tina Abraham, MD
CSL Behring
Thursday, May 29, 2025
6:35 – 7:20 PM ~ Ponce 3
Exploring the Burden and Management of Hereditary Angioedema:
Optimizing Long-Tern Prophylaxis From the Start
Mark Glaum, MD
---------------------------------------------------------------------------------------------------------------
Sanofi & Regeneron
Friday, May 30, 2025
6:55 – 7:40 AM ~ Ponce 1&2 ~ Breakfast Product Theater
Interconnectivity of Type 2 Inflammation Across Select Diseases
Michael Blaiss, MD
Novartis
Friday, May 30, 2025
6:55 – 7:40 AM ~ Ponce 3 ~ Breakfast Product Theater
Unlocking Chronic Spontaneous Urticaria (CSU): Exploring the Role of Bruton’s tyrosine
kinase (BTK) in Pathophysiology, Unmet Needs, and Disease Burden
Jonathan Rodrigues, MD
Sanofi & Regeneron
Friday, May 30, 2025
12:30 – 1:15 PM ~ Ponce 1&2 ~ Lunch Product Theater
JOIN US FOR A DISCUSSION ON DUPIXENT® (dupilumab)
A Biologic You Know, Now Approved in Chronic Spontaneous Urticaria (CSU)
Giselle Mosnaim, MD
Incyte
Friday, May 30, 2025
12:30 – 1:15 PM ~ Ponce 3 ~ Lunch Product Theater
Mild to Moderate Atopic Dermatitis in your Practice; Burden of Disease and a Topical Pathway for JAK Inhibition
Shahnaz Fatteh, MD
Genentech
Friday, May 30, 2025
6:00 – 7:00 PM ~ Ponce 1&2
Xolair, A Therapeutic Option for IgE Mediated Food Allergy
Kevin Murphy, MD
-------------------------------------------------------------------------------------------------------------
AstraZeneca
Saturday, May 31, 2025
6:55 – 7:40 AM ~ Ponce 1&2 ~ Breakfast Product Theater
One Approach, Many Patients: Addressing Eosinophilic Inflammation
Bill McCann, MD and Shahnaz Fatteh, MD
Takeda
Saturday, May 31, 2025
6:55 – 7:40 AM ~ Ponce 3 ~ Breakfast Product Theater
CUVITRU – Optimizing Ig Treatment for People Living With Primary Immunodeficiency
Vivian Hernandez-Trujillo, MD
Amgen/AstraZeneca
Saturday, May 31, 2025
12:30 – 1:15 PM ~ Ponce 1&2 ~ Lunch Product Theater
Many Triggers, A Targeted Approach: Helping to Understand the Spectrum of Severe Asthma
Holly McPherson, MD and Nicholas Kolinsky, DO
Takeda
Saturday, May 31, 2025
12:30 – 1:15 PM ~ Ponce 3 – Lunch Product Theater
Hereditary Angioedema (HAE): Clinical Data and Experience of Proven Effective Prevention
Raffi Tachdjian, MD
_____________________________________________________________________
Genentech
Sunday, June 1, 2025
7:25 – 8:10 AM Ponce 1&2 ~ Breakfast Product Theater
Bridging the Gap: Real-World Strategies for Implementing Cutting-Edge Therapies for Multiple Food Allergies
Moderator: Julie Wang, MD Panelist: Amy CaJacob, MD and Ruchi Gupta, MD
GlaxoSmithKline
Sunday, June 1, 2025
7:25 – 8:10 AM ~ Ponce 3 ~ Breakfast Product Theater
GSK respiratory biologic Product Theater ß Pending APPROVAL
Maeve O’Connor, MD
AstraZeneca
Sunday, June 1, 2025
9:25 – 10:10 AM ~ Ponce 1&2 ~ Product Theater
Unlock a Fresh Perspective on CRSwNP: Investigating Epithelial Cytokines
Katie Buchheit, MD
Eli Lilly
Sunday, June 1, 2025
9:25 – 10:10 AM ~ Ponce 3
Experience EBGLYSSTM (lebrikizumab-lbkz): Consider This Option for Your Patients
Bob Geng, MD
__________________________________________________________________________________
*Please note that attendance of Product Theaters is an option only available to full conference registrants and is not for CME credit. Entrance requires for your name badge to be scanned; and by attending, you are granting access to your contact information (but not your email address).
